Archives of oto-rhino-laryngology

, Volume 245, Issue 5, pp 293–296 | Cite as

Transtympanic administration of aminoglycosides in patients with Menière's disease

Original Investigations


Transtympanic administration of gentamicin was used to treat patients with unilateral Menière's disease and was stopped at the first signs of damage to cochlear and/or vestibular function. Twenty-eight patients were treated between 1974 and 1981 and 34 patients were managed between 1981 and 1987. In the two groups of patients, objective vertigo disappeared in 85%, hearing improved in 26%, aural fullness disappeared in 78%, while tinnitus ceased altogether in 51% and became less intense in 24%. Our findings show that this kind of treatment can be used after unsuccessful medical therapy and prior to any labyrinthine or endolymphatic sac surgery.

Key words

Menière's disease Aminoglycosides-Transtympanic gentamicin Vertigo Tinnitus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arslan M (1978) A new hypothesis on the plurifocal etiology of Menière's disease. Acta Otolaryngol (Stockh) 86 [Suppl 357]:1–19Google Scholar
  2. 2.
    Beck C (1985) Intratympanic application of gentamicin for treatment of Menière's disease. Kejo J Med 35:36–41Google Scholar
  3. 3.
    Beck C, Schmidt C (1978) 10 years of experience with intratympanically applied streptomicin (gentamycin) in the therapy of morbus Menière. Arch Ital Oto-Rhino-Laryngol 221:149–152Google Scholar
  4. 4.
    Catalano GB, Conticello S, Serra A (1983) Modificazioni ultrastrutturali degli otoliti nella intossicazione cronica da aminoglicosidi. Acta Oto-Rhino-Laryngol Ital 3:373–380Google Scholar
  5. 5.
    De Vincentiis I, Ralli G (1980) Nuovi orientamenti sulla patogenesi e terapia della malattia di Menière. Attualità in Otorinolaringologia. Valeas, Milano, pp 105–112Google Scholar
  6. 6.
    Doley E, Tamir A, Leventon G (1983) Is magnesium depletion the reason for ototoxicity caused by aminoglycosides? Med Hypotheses 10:353–358Google Scholar
  7. 7.
    Federspil P (1984) Ototoxicität Grenzdosen. HNO 32:417–418Google Scholar
  8. 8.
    Feldbaum JS, Silverstein H (1984) Streptomycin drug fever during treatment of bilateral Menière's disease. Arch Otolaryngol 110:538–539Google Scholar
  9. 9.
    Forge A, Fradis M (1985) Structural abnormalities in the stria vascularis following chronic gentamicin treatment. Hear Res 20:223–224Google Scholar
  10. 10.
    Gavilan J, Gavilan C (1984) Middle fossa vestibular neurectomy. Long-term results. Arch Otolaryngol 110:785–787Google Scholar
  11. 11.
    Graham MD, Sataloff RT, Kemink JL (1984) Tinnitus in Menière's disease: response to titration streptomycin therapy. J Laryngol Otol 98:281–286Google Scholar
  12. 12.
    Hayashida T, Nomura Y, Iwamori M, Nagai Y, Kurata T (1985) Distribution of gentamicin by immunofluorescence in the guinea pig inner ear. Arch Otorhinolaryngol 242:257–264Google Scholar
  13. 13.
    House JW (1981) Panel on tinnitus control. Management of the tinnitus patient. Ann Otol 90:597–601Google Scholar
  14. 14.
    Huizing EH, Kuper-Carriere EJG, Tange RA (1985) Results of clinical, electrophysiological and histological investigations of gentamycin ototoxicity. Riv Ital ORL Aud Fon 5:67–73Google Scholar
  15. 15.
    Lange G (1977) Die intratympanale Behandlung des Morbus Menière mit ototoxischen Antibiotica. Arch Laryngol Rhinol Otol 56:409–414Google Scholar
  16. 16.
    Lange G (1981) Die Indikation zur intratympanale Gentamycin-Behandlung der Menièreschen Krankheit. HNO 29:49–51Google Scholar
  17. 17.
    Lange G (1985) Technische Schwierigkeiten bei der intratympanale Gentamycin-Therapie des Morbus Menière. Laryngol Rhinol Otol 64:174Google Scholar
  18. 18.
    Lee SJ, Harpur ES (1984) Acute effects of gentamycin and furosemide on guinea pig cochlear potentials. Br J Audiol 18:245–259Google Scholar
  19. 19.
    Marullo T, Filipo R, Fabiani M (1980) Il problema terapeutico della malattia di Menière. Attualità in otorinolaringologia. Valeas, Milan, pp 157–179Google Scholar
  20. 20.
    Morgenstern C, Ninoyu O, Mori N, Mertens HP (1986) Zur Wirkung von Aminoglycosides auf den experimentell erzeugten endolymphatischen Hydrops. Laryngol Rhinol Otol 65:371–373Google Scholar
  21. 21.
    Motta G, Jengo M (1983) Invited lectures on “tinnitus” at the LXX National Congress of the Italian ENT Society (SIO & Ch C Fac) 25–28 May 1983, Bologna. SIO, RomeGoogle Scholar
  22. 22.
    Ohtani I, Ohtsuki K, Aikawa T (1982) Evaluation of ototoxicity of aminoglycoside antibiotic in rabbits. Auris Nasus Larynx 9:67–74Google Scholar
  23. 23.
    Ottaviani A, Bergomi A (1983) Invited lectures on “tinnitus” at the LXX National Congress of the Italian ENT Society (SIO & Ch C Fac), 25–28 May, Bologna, SIO, RomeGoogle Scholar
  24. 24.
    Paparella MM (1984) Pathogenesis of Menière's disease and Menière's syndrome. Acta Otolaryngol (Stockh) [Suppl 406]:10–25Google Scholar
  25. 25.
    Pappas DG (1984) Diagnostic correlations between tinnitus and Menière's disease as determined by computerized rotary chair. J Laryngol Otol 98 [Suppl 9]:184–187Google Scholar
  26. 26.
    Pender DJ (1985) Gentamycin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol Head Neck Surg 6:358–367Google Scholar
  27. 27.
    Sala O (1977) Otorinolaringojatria. In: Roversi AA (ed) Manuale medico di diagnostica e terapia. Gruppo Lepetit, Milan, pp 946–1013Google Scholar
  28. 28.
    Sala T (1981) Transtympanic administration of gentamycin in the treatment of Menière's disease. Riv Ital ORL Aud Fon 1:209–213Google Scholar
  29. 29.
    Schuknecht H (1957) Ablation therapy in the management of Menière's disease. Acta Otolaryngol (Stockh) [Suppl 132]:1–42Google Scholar
  30. 30.
    Schmidt C, Beck C (1980) Behandlung des morbus Menière mit intratympanal applizierten Gentamycin-Sulfat. Laryngol Rhinol 59:804–807Google Scholar
  31. 31.
    Silverstein H (1984) Streptomycin treatment for Menière's disease. Ann Otol 93 [Suppl 112]:44–48Google Scholar
  32. 32.
    Silverstein H, Hyman SM, Feldbaum J, Silverstein D (1984) Use of streptomycin sulfate in the treatment of Menière's disease. Am J Otolaryngol Head Neck Surg 92:229–232Google Scholar
  33. 33.
    Wang BM, Weiner ND, Takada A, Schacht J (1984) Characterization of aminoglycoside-lipid interactions and development of a rifined model for ototoxicity testing. Biochem Pharmacol 33:3257–3262Google Scholar
  34. 34.
    Williams SE (1987) Characteristics of gentamycin uptake in the isolated crista ampullaris of the inner ear of the guinea pig. Biochem Pharmacol 36:89–95Google Scholar
  35. 35.
    Zenner HP (1986) K+-induced motility and depolarisation of cochlear hair cells. Direct evidence of a new pathophysiological mechanism in Menière's disease. Arch Otorhinolaryngol 243:108–111Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • T. Sala
    • 1
  1. 1.ENT DepartmentHospital of MestreVeniceItaly

Personalised recommendations